Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Development of Type 2 Diabetes Mellitus Drugs: State of the Art Cardiovascular Safety Assessments

5 - 6 October 2010, Washington DC, United States


Introduction
Interact with Senior FDA Members to Explore Emerging Issues in Cardiovascular Safety and Diabetic Drug Development Event Code:
10035
Venue
L’Enfant Plaza Hotel

L’Enfant Plaza Hotel, Washington DC, United States

Organised by
DIA
Contact information
Rachel Minnick
215.442.6131
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*